Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA-937 (miR-937) is a small, non-coding RNA molecule approximately 21–24 nucleotides long, encoded in the human genome (chromosome 8) and classified under the microRNA family. It functions in post-transcriptional gene regulation by binding to complementary sequences in target mRNA, leading to mRNA degradation or translational inhibition, thereby modulating the expression of proteins involved in neuronal repair and potentially cancer progression. Experimental studies in Alzheimer’s disease models indicate that antisense-mediated inhibition of miR-937 can increase the neurotrophic factor BDNF, suggesting a role for miR-937 in neuronal repair pathways. miR-937 is also implicated in certain cancers, including cervical and endocrine gland cancers, but its precise pathogenic mechanisms in oncology remain less well characterized compared to its role in neurodegenerative processes. Currently, no drugs are known to directly target miR-937 in clinical use, and its therapeutic potential is still under investigation.
Inhibits expression of target genes (e.g., BDNF, Brn-4) via miRNA-mediated RNA silencing, primarily by destabilizing mRNA or inhibiting translation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA-937 (miR-937) (miR-937).